Resultats de la cerca - Merit Cudkowicz

Refinar resultats
  1. 1
    A futility study of minocycline in Huntington's disease

    A futility study of minocycline in Huntington's disease per Merit Cudkowicz

    Publicat 2010
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    ALS Drug Development: Reflections from the Past and a Way Forward

    ALS Drug Development: Reflections from the Past and a Way Forward per Swati Aggarwal, Merit Cudkowicz

    Publicat 2008
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  3. 3
    Outcome measures in amyotrophic lateral sclerosis clinical trials

    Outcome measures in amyotrophic lateral sclerosis clinical trials per Sabrina Paganoni, Merit Cudkowicz, James Berry

    Publicat 2014
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis

    Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis per Sabrina Paganoni, Jing Deng, Matthew Jaffa, Merit Cudkowicz, Anne‐Marie Wills

    Publicat 2011
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Race/ethnicity, socioeconomic status, and ALS mortality in the United States

    Race/ethnicity, socioeconomic status, and ALS mortality in the United States per Andrea L. Roberts, Norman J. Johnson, Jarvis T. Chen, Merit Cudkowicz, Marc G. Weisskopf

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Depression in amyotrophic lateral sclerosis

    Depression in amyotrophic lateral sclerosis per Nazem Atassi, Amanda Cook, Cristiana M. Pineda, Padmaja Yerramilli-Rao, Darlene Pulley, Merit Cudkowicz

    Publicat 2010
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    Facial onset sensory and motor neuronopathy (FOSMN syndrome): a novel syndrome in neurology

    Facial onset sensory and motor neuronopathy (FOSMN syndrome): a novel syndrome in neurology per Steve Vucic, Di Tian, Peter Siao Tick Chong, Merit Cudkowicz, E. T. Hedley‐Whyte, David Cros

    Publicat 2006
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    Randomized, double-blind, placebo-controlled trial of arimoclomol in rapidly progressive <i>SOD1</i> ALS

    Randomized, double-blind, placebo-controlled trial of arimoclomol in rapidly progressive <i>SOD1</i> ALS per Michael Benatar, Joanne Wuu, Peter M. Andersen, Nazem Atassi, William David, Merit Cudkowicz, David Schoenfeld

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Uric acid levels predict survival in men with amyotrophic lateral sclerosis

    Uric acid levels predict survival in men with amyotrophic lateral sclerosis per Sabrina Paganoni, May Zhang, Alejandro Quiroz Zárate, Matthew Jaffa, Hong Yu, Merit Cudkowicz, Anne‐Marie Wills

    Publicat 2012
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Association of Polyunsaturated Fatty Acids and Clinical Progression in Patients With ALS

    Association of Polyunsaturated Fatty Acids and Clinical Progression in Patients With ALS per Kjetil Bjørnevik, Marianna Cortese, Jeremy D. Furtado, Sabrina Paganoni, Michael A. Schwarzschild, Merit Cudkowicz, Alberto Ascherio

    Publicat 2023
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Diagnostic timelines and delays in diagnosing amyotrophic lateral sclerosis (ALS)

    Diagnostic timelines and delays in diagnosing amyotrophic lateral sclerosis (ALS) per Sabrina Paganoni, Eric A. Macklin, Alexandra Lee, Alyssa Murphy, Judith Chang, Amanda Zipf, Merit Cudkowicz, Nazem Atassi

    Publicat 2014
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    Quantitative strength testing in ALS clinical trials

    Quantitative strength testing in ALS clinical trials per Jeremy M. Shefner, Dawei Liu, Melanie Leitner, David Schoenfeld, Donald R. Johns, Toby A. Ferguson, Merit Cudkowicz

    Publicat 2016
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    Galectin-3 Is a Candidate Biomarker for Amyotrophic Lateral Sclerosis: Discovery by a Proteomics Approach

    Galectin-3 Is a Candidate Biomarker for Amyotrophic Lateral Sclerosis: Discovery by a Proteomics Approach per Jianying Zhou, Leila Afjehi‐Sadat, Pamela J. Shaw, Duc M. Duong, Merit Cudkowicz, Jonathan D. Glass, Junmin Peng

    Publicat 2010
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics

    Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics per Henrik Ryberg, Jiyan An, Samuel Darko, Jonathan L. Lustgarten, Matt Jaffa, Vanathi Gopalakrishnan, David Lacomis, Merit Cudkowicz, Robert Bowser

    Publicat 2010
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    Urate levels predict survival in amyotrophic lateral sclerosis: Analysis of the expanded Pooled Resource Open‐Access ALS clinical trials database

    Urate levels predict survival in amyotrophic lateral sclerosis: Analysis of the expanded Pooled Resource Open‐Access ALS clinical trials database per Sabrina Paganoni, Katharine Nicholson, James Chan, Amy M. Shui, David Schoenfeld, Alexander Sherman, James Berry, Merit Cudkowicz, Nazem Atassi

    Publicat 2017
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    Survival analyses from the <scp>CENTAUR</scp> trial in amyotrophic lateral sclerosis: Evaluating the impact of treatment crossover on outcomes

    Survival analyses from the <scp>CENTAUR</scp> trial in amyotrophic lateral sclerosis: Evaluating the impact of treatment crossover on outcomes per Sabrina Paganoni, Claire Watkins, Matthew Cawson, Suzanne Hendrix, Samuel P. Dickson, Newman Knowlton, Jamie Timmons, Machelle Manuel, Merit Cudkowicz

    Publicat 2022
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Developing multidisciplinary clinics for neuromuscular care and research

    Developing multidisciplinary clinics for neuromuscular care and research per Sabrina Paganoni, Katie Nicholson, Fawn Leigh, Kathryn J. Swoboda, David A. Chad, Kristin Drake, Kellen Haley, Merit Cudkowicz, James Berry

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  18. 18
    Expanded autologous regulatory T-lymphocyte infusions in ALS

    Expanded autologous regulatory T-lymphocyte infusions in ALS per Jason R. Thonhoff, David R. Beers, Weihua Zhao, Milvia Pleitez, Ericka P. Simpson, James Berry, Merit Cudkowicz, Stanley H. Appel

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis

    Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis per Srikanth Ranganathan, Eric O. Williams, Philip Ganchev, Vanathi Gopalakrishnan, David Lacomis, Leo Urbinelli, Kristyn Newhall, Merit Cudkowicz, Robert H. Brown, Robert Bowser

    Publicat 2005
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    How common are ALS plateaus and reversals?

    How common are ALS plateaus and reversals? per Richard Bedlack, Timothy E. Vaughan, Paul Wicks, Jamie Heywood, Ervin Sinani, Roger Selsov, Eric A. Macklin, David Schoenfeld, Merit Cudkowicz, Alex Sherman

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: